ArticleBMC cancer2021

Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.

Shun Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.